Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+

NCT06919328 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-04-09

No results posted yet for this study

Summary

This study evaluates the subjective effects of injection administration of NR on healthy adult populations.

Conditions

  • Healthy Aging

Interventions

DIETARY_SUPPLEMENT

Niagen®

nicotinamide riboside

OTHER

NAD+

Nicotinamide adenine dinucleotide

OTHER

Placebo

bacteriostatic water

Sponsors & Collaborators

  • ChromaDex, Inc.

    collaborator INDUSTRY
  • Nutraceuticals Research Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2025-04-30
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06919328 on ClinicalTrials.gov